Pradžia › Krono liga › Texas › Lubbock
Krono liga klinikiniai tyrimai Lubbock, TX
10 tyrimai dėl Krono liga ieško dalyvių vietose Lubbock ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Renkami dalyviai3 fazė
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Renkami dalyviai3 fazė
- Caprock Gastro Research ( Site 5077), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Renkami dalyviai2 fazė
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Renkami dalyviai4 fazė
- West Texas Research Institute, Lubbock
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Renkami dalyviai2 fazė
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
- Lubbock Gastroenterology, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Renkami dalyviai3 fazė
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Renkami dalyviai4 fazė
- Texas Digestive Disease Consultants Lubbock, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Renkami dalyviai2 fazė
- Mirador Therapeutics Selected Site, Lubbock
Krono liga tyrimai kituose miestuose
- New York City, NY35 tyrimai
- Cleveland, OH19 tyrimai
- St. Louis, MO19 tyrimai
- Boston, MA19 tyrimai
- Miami, FL19 tyrimai
- Orlando, FL17 tyrimai
- Houston, TX17 tyrimai
- Atlanta, GA17 tyrimai
- Tyler, TX16 tyrimai
- San Diego, CA15 tyrimai
- San Antonio, TX15 tyrimai
- Los Angeles, CA15 tyrimai
Kiti tyrimai Lubbock
- Opinis kolitas9 tyrimai
- Krūties vėžys6 tyrimai
- Nedidelinių ląstelių plaučių vėžys4 tyrimai
- Psoriazinis artritas3 tyrimai
- Insultas3 tyrimai
- Antsvoris3 tyrimai
- Nutukimas3 tyrimai
- Uždegiminė žarnyno liga3 tyrimai
- Berkito limfoma3 tyrimai
- Kartotinė mieloma3 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.